Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its holdings in Astrana Health, Inc. (NASDAQ:ASTH) by 0.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 266,876 shares of the company’s stock after selling 1,826 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.47% of Astrana Health worth $8,415,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Janus Henderson Group PLC acquired a new position in shares of Astrana Health in the third quarter worth about $1,164,000. Royce & Associates LP acquired a new stake in Astrana Health during the third quarter valued at approximately $6,661,000. Amalgamated Bank acquired a new stake in Astrana Health during the third quarter valued at approximately $713,000. Principal Financial Group Inc. acquired a new stake in Astrana Health during the third quarter valued at approximately $13,383,000. Finally, Loomis Sayles & Co. L P acquired a new stake in Astrana Health during the third quarter valued at approximately $30,251,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Bank of America cut their price objective on Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a research note on Tuesday, March 4th. Truist Financial cut their price objective on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. Stifel Nicolaus cut their price objective on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Robert W. Baird cut their price objective on Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. Finally, Macquarie raised Astrana Health to a “hold” rating in a report on Monday, December 16th. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $56.83.

Astrana Health Stock Up 0.5 %

NASDAQ:ASTH opened at $29.34 on Friday. The firm has a market capitalization of $1.65 billion, a PE ratio of 22.57, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The stock has a 50 day moving average of $34.02 and a 200-day moving average of $43.27. Astrana Health, Inc. has a 52 week low of $23.12 and a 52 week high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $665.21 million during the quarter, compared to the consensus estimate of $617.24 million. Analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.